|
|
|
| Webinar: Streamlining Biotherapy QC: Practical Solutions for Protein Analytics & Residual DNA Testing | Biologic therapies are transforming healthcare—but complex QC challenges can slow progress. Join this Thermo Fisher Scientific webinar to uncover common pitfalls in HPLC protein analytics and residual DNA testing, debunk persistent myths, and gain practical strategies to enhance robustness and reproducibility. Learn how proactive QC planning can streamline workflows and accelerate biotherapeutic development. Click here to learn more. |
|
|
FOCUS ON REGULATORY & COMPLIANCE |
|
|
|
This is Episode 4 of "FDA Fridays," a special series from Cell & Gene: The Podcast, Chief Editor Erin Harris speaks with regulatory affairs expert Daniela Drago, Partner, NDA Partners, about how shifting FDA and CBER priorities under the current administration could influence the trajectory of cell and gene therapy development. |
|
|
|
|
|
| What Your Environmental Monitoring Isn't Telling You | Webinar | Contec, Inc. | View often overlooked contamination sources, like residues, poor housekeeping, and training gaps, which offer practical, actionable strategies to strengthen and optimize your contamination control program. |
|
|
|
|
| 5 Ways To Drive Lab Sustainability | Article | PHC Corporation of North America | Laboratories drive innovation, but their environmental impact is growing. Learn five practical tips to make your lab more sustainable to reduce waste, and support global climate goals. |
|
|
|
| The Hidden Cost Of Off-The-Shelf Media In Cell Therapy | Article | By Asma Ayari, Ph.D., Nucleus Biologics | Generic, off-the-shelf media can introduce hidden costs and delays in cell and gene therapy development. A strategic media approach is a critical advantage that can accelerate your path to the clinic. |
|
|
|
| Recombinant Trypsin Frequently Asked Questions | Article | Roche CustomBiotech | Assimilate more about the key features of a high-quality recombinant trypsin and how it can benefit your bioprocess with insightful answers to these common questions. |
|
|
|
|
| Join life sciences experts and global regulators this 9–10 December for the 2025 ISPE Pharma 4.0™ Conference in Barcelona, Spain, or virtually. This year's agenda spotlights how innovative enabling technologies including AI, machine learning, virtual and augmented reality, industrial internet of things, GxP cloud platforms, robotics, advanced modeling, and automation, are addressing key challenges like drug shortages and improving product availability. |
|
|
REGULATORY & COMPLIANCE SOLUTIONS |
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|